Table 1.

Demographic and clinical characteristics of study participants

Characteristics	Value (N=90)
Sex
Male	45 (50.0)
Female	45 (50.0)
Age (yr)	37.92±12.57
Education (yr)	14.61±2.29
Intracranial volume (mL)	1494.54±153.91
Age of symptom onset (yr) (N=82)	33.26±12.11
Duration of illness (mo) (N=69)	46.45±79.96
Family history of anxiety disorder	24 (26.7)
Baseline IUS	31.60±6.81
Baseline PDSS	13.08±6.55
Baseline BDI-II (N=88)	17.08±9.67
Baseline PSWQ (N=87)	53.15±12.52
Baseline BAI (N=85)	23.69 ±14.82
Baseline SFS (N=32)	61.25±8.06
Acceptance and improvement	26.72 ±5.31
Transferring of responsibility	17.97±3.66
Negative affect, thought, and behavior	16.56±4.13
Baseline SF (N=81)	1844.75±454.96
Physical functioning	72.61±20.34
Social functioning	58.10±19.70
Role physical	28.41±37.75
Role emotional	27.20±37.54
Mental health	50.50±8.05
Vitality	49.24±11.34
Bodily pain	50.67±30.14
General health	42.27±16.57

Values are presented as mean±standard deviation or number (%).

IUS, Intolerance of Uncertainty Scale; PDSS, Panic Disorder Severity Scale; BDI-II, Beck Depression Inventory-II; PSWQ, Penn State Worry Questionnaire; BAI, Beck Anxiety Inventory; SFS, Self-Forgiveness Scale; SF, Short-Form 36-Item Health Survey